home / news releases


Motley Fool News Releases and Press Releases From 07/10/24

Now Trending

Company Name:Lemonade Inc.
Stock Symbol:LMND
Market:NYSE
Website:lemonade.com

Menu

LMND LMND Quote LMND Short LMND News LMND Articles LMND Message Board
Get Alerts

News, Short Squeeze, Breakout and More Instantly...

Search News Releases

BIDU - 3 Reasons Baidu Stock Can Bounce Back in 2024

2024-07-10 07:30:00 ET The trend is not the friend for Baidu (NASDAQ: BIDU) shareholders. China's iconic search engine finds its stock trading 20% lower in the otherwise buoyant 2024, off a blistering 33% over the past year. Many Chinese investments have fallen out of favor lately, ...

AMZN - 3 Brilliant Reasons to Buy Amazon Stock Right Now

2024-07-10 07:15:00 ET Amazon (NASDAQ: AMZN) is one of the latest additions to the $2 trillion valuation club. This exclusive group comprises only five companies, but these also happen to be some of the most dominant businesses on the globe. While many in this group have strong ...

BTI - 1 Spectacular Dividend Stock Yielding Close to 10% to Buy for the Second Half of 2024

2024-07-10 07:13:00 ET The market has soared since the beginning of 2023. The S&P 500 index has posted a total return level of 48% over that time frame, pushing the index's price-to-earnings ( P/E ) ratio of nearly 29. This is much higher than the long-term market average, w...

IONQ - Is IonQ Stock a Buy Now?

2024-07-10 06:53:00 ET Quantum computing expert IonQ (NYSE: IONQ) is going through a tricky growth spurt. First-quarter revenues rose by 77% year over year, but the company is burning lots of cash. Meanwhile, investors have turned away from the previously red-hot quantum computing i...

VKTX - Better GLP-1 Biotech Stock: Altimmune vs. Viking Therapeutics

2024-07-10 06:41:00 ET Altimmune (NASDAQ: ALT) and Viking Therapeutics (NASDAQ: VKTX) are a pair of biotechs planning to follow in the footsteps of Novo Nordisk and Eli Lilly and develop GLP-1-targeted medicines for obesity like Wegovy and Zepbound. Both companies ha...

ALT - Better GLP-1 Biotech Stock: Altimmune vs. Viking Therapeutics

2024-07-10 06:41:00 ET Altimmune (NASDAQ: ALT) and Viking Therapeutics (NASDAQ: VKTX) are a pair of biotechs planning to follow in the footsteps of Novo Nordisk and Eli Lilly and develop GLP-1-targeted medicines for obesity like Wegovy and Zepbound. Both companies ha...

WBA - Walgreens Boots Alliance Stock Hits 27-Year Lows. Has It Become a Steal of a Deal?

2024-07-10 06:23:00 ET Buying a stock on weakness can be a dangerous idea. Imagine a stock that you think may be a decent buy falls to a new 52-week low. Then a few weeks later, it hits a new low. Then another. And after a while of this tailspin, it's at a multiyear low. That's what m...

MSFT - 1 Mind-Boggling Fact About Microsoft's Stock That Will Make You Think Twice About the Importance of Valuations

2024-07-10 06:15:00 ET If you buy and hold a quality stock for the long term, you expect to earn a good return. But often, I see investors dismiss valuations because the argument is that everything will sort itself out in the long run -- and that can be a dangerous assumption. If you bu...

FVRR - 1 Tech Stock Down 90% You'd Regret Not Buying on the Dip

2024-07-10 06:15:00 ET Equities performed well over the past few years, but that will be cold comfort to Fiverr 's (NYSE: FVRR) shareholders. The tech company has seen its shares plunge by a whopping 90% in the past three years -- an abysmal performance by almost any metric. One cou...

O - This Dirt Cheap Stock Has Raised Its Dividend for Over 25 Years in a Row. Here's Why It's Worth a Look Right Now.

2024-07-10 06:12:00 ET Realty Income (NYSE: O) is one of the largest and most popular real estate investment trusts, or REITs, in the market. The company owns a portfolio of nearly 15,500 properties in the United States and Europe and has paid 647 consecutive monthly dividends to in...

Previous 10 Next 10